Cargando…

Plasmepsin-like Aspartyl Proteases in Babesia

Apicomplexan genomes encode multiple pepsin-family aspartyl proteases (APs) that phylogenetically cluster to six independent clades (A to F). Such diversification has been powered by the function-driven evolution of the ancestral apicomplexan AP gene and is associated with the adaptation of various...

Descripción completa

Detalles Bibliográficos
Autores principales: Šnebergerová, Pavla, Bartošová-Sojková, Pavla, Jalovecká, Marie, Sojka, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540915/
https://www.ncbi.nlm.nih.gov/pubmed/34684190
http://dx.doi.org/10.3390/pathogens10101241
_version_ 1784589102447853568
author Šnebergerová, Pavla
Bartošová-Sojková, Pavla
Jalovecká, Marie
Sojka, Daniel
author_facet Šnebergerová, Pavla
Bartošová-Sojková, Pavla
Jalovecká, Marie
Sojka, Daniel
author_sort Šnebergerová, Pavla
collection PubMed
description Apicomplexan genomes encode multiple pepsin-family aspartyl proteases (APs) that phylogenetically cluster to six independent clades (A to F). Such diversification has been powered by the function-driven evolution of the ancestral apicomplexan AP gene and is associated with the adaptation of various apicomplexan species to different strategies of host infection and transmission through various invertebrate vectors. To estimate the potential roles of Babesia APs, we performed qRT-PCR-based expressional profiling of Babesia microti APs (BmASP2, 3, 5, 6), which revealed the dynamically changing mRNA levels and indicated the specific roles of individual BmASP isoenzymes throughout the life cycle of this parasite. To expand on the current knowledge on piroplasmid APs, we searched the EuPathDB and NCBI GenBank databases to identify and phylogenetically analyse the complete sets of APs encoded by the genomes of selected Babesia and Theileria species. Our results clearly determine the potential roles of identified APs by their phylogenetic relation to their homologues of known function—Plasmodium falciparum plasmepsins (PfPM I–X) and Toxoplasma gondii aspartyl proteases (TgASP1–7). Due to the analogies with plasmodial plasmepsins, piroplasmid APs represent valuable enzymatic targets that are druggable by small molecule inhibitors—candidate molecules for the yet-missing specific therapy for babesiosis.
format Online
Article
Text
id pubmed-8540915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85409152021-10-24 Plasmepsin-like Aspartyl Proteases in Babesia Šnebergerová, Pavla Bartošová-Sojková, Pavla Jalovecká, Marie Sojka, Daniel Pathogens Article Apicomplexan genomes encode multiple pepsin-family aspartyl proteases (APs) that phylogenetically cluster to six independent clades (A to F). Such diversification has been powered by the function-driven evolution of the ancestral apicomplexan AP gene and is associated with the adaptation of various apicomplexan species to different strategies of host infection and transmission through various invertebrate vectors. To estimate the potential roles of Babesia APs, we performed qRT-PCR-based expressional profiling of Babesia microti APs (BmASP2, 3, 5, 6), which revealed the dynamically changing mRNA levels and indicated the specific roles of individual BmASP isoenzymes throughout the life cycle of this parasite. To expand on the current knowledge on piroplasmid APs, we searched the EuPathDB and NCBI GenBank databases to identify and phylogenetically analyse the complete sets of APs encoded by the genomes of selected Babesia and Theileria species. Our results clearly determine the potential roles of identified APs by their phylogenetic relation to their homologues of known function—Plasmodium falciparum plasmepsins (PfPM I–X) and Toxoplasma gondii aspartyl proteases (TgASP1–7). Due to the analogies with plasmodial plasmepsins, piroplasmid APs represent valuable enzymatic targets that are druggable by small molecule inhibitors—candidate molecules for the yet-missing specific therapy for babesiosis. MDPI 2021-09-26 /pmc/articles/PMC8540915/ /pubmed/34684190 http://dx.doi.org/10.3390/pathogens10101241 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Šnebergerová, Pavla
Bartošová-Sojková, Pavla
Jalovecká, Marie
Sojka, Daniel
Plasmepsin-like Aspartyl Proteases in Babesia
title Plasmepsin-like Aspartyl Proteases in Babesia
title_full Plasmepsin-like Aspartyl Proteases in Babesia
title_fullStr Plasmepsin-like Aspartyl Proteases in Babesia
title_full_unstemmed Plasmepsin-like Aspartyl Proteases in Babesia
title_short Plasmepsin-like Aspartyl Proteases in Babesia
title_sort plasmepsin-like aspartyl proteases in babesia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540915/
https://www.ncbi.nlm.nih.gov/pubmed/34684190
http://dx.doi.org/10.3390/pathogens10101241
work_keys_str_mv AT snebergerovapavla plasmepsinlikeaspartylproteasesinbabesia
AT bartosovasojkovapavla plasmepsinlikeaspartylproteasesinbabesia
AT jaloveckamarie plasmepsinlikeaspartylproteasesinbabesia
AT sojkadaniel plasmepsinlikeaspartylproteasesinbabesia